Synergy for Streptococcal Endocarditis
Streptococcal endocarditis, a subset of infective endocarditis (IE), predominantly affects native heart valves and is most commonly caused by viridans group streptococci (VGS), Streptococcus bovis,…
Synergy in the Treatment of Pseudomonas aeruginosa Osteomyelitis
Pseudomonas aeruginosa is a Gram-negative, opportunistic pathogen notorious for its role in chronic and hard-to-treat infections, especially osteomyelitis. Its ability to form biofilms, resist multiple…
Synergy for Pseudomonas aeruginosa Joint Infection
Pseudomonas aeruginosa is an opportunistic, Gram-negative, non-fermenting bacillus responsible for a subset of joint infections, particularly in immunocompromised individuals, intravenous drug users, or patients with…
Synergy for Enterococcal Endocarditis
Enterococcal endocarditis, predominantly caused by Enterococcus faecalis and Enterococcus faecium, is a severe manifestation of infective endocarditis (IE) characterized by high morbidity and therapeutic complexity.…